Top-News

Roche Holding Aktie (ADR) News

Aktie
WKN:  891106 ISIN:  US7711951043 US-Symbol:  RHHBY Branche:  Pharmazeutika Land:  Schweiz
41,324 €
+0,19 €
+0,46%
10:13:22 Uhr
Depot/Watchlist
Marktkapitalisierung *
213,51 Mrd. €
Streubesitz
99,18%
KGV
11,84
Dividende
1,36 $
Dividendenrendite
2,82%
Faktor
8
Originalaktie
CH0012032048

Roche Holding Aktie (ADR) News

12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
13.10.25 - PR Newswire
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
Roche's Elecsys® pTau181 becomes the only FDA-​cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology PR Newswire
18.09.25 - PR Newswire
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test PR Newswire
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
24.07.25 - PR Newswire
Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
Roche Diagnostics showcases science-​driven leadership and innovation at ADLM 2025 PR Newswire
07.07.25 - PR Newswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs PR Newswire
07.07.25 - PR Newswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs PR Newswire
12.05.25 - PR Newswire
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire
02.04.25 - PR Newswire
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Quest Diagnostics Introduces HPV Specimen Self-​Collection for Cervical Cancer Screening PR Newswire
23.02.25 - wallstreetONLINE Redaktion
Crash-Vorsorge: 1 krisensichere Dividenden-Aktie mit 3,3 % Rendite & 38 Jahre Dividendenwachstum
Starinvestor Warren Buffett erhöht zunehmend die Defensive. Diese Aktie erfüllt viele seiner Kriterien.Gerade wenn Aktien stetig steigen, erscheint ein größerer Rückschlag ...
25.01.25 - Börse-Global
Roche Aktie: Dynamische Marktstellung!
Die Roche Holding verzeichnet aktuell positive Entwicklungen an den Märkten. Der Schweizer Pharmakonzern konnte sich über einen bedeutenden regulatorischen Durchbruch im ...
13.01.25 - PR Newswire
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Roche receives FDA clearance for new, highly-​sensitive test to aid clinicians in diagnosing B-cell lymphoma PR Newswire
09.01.25 - PR Newswire
Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner
Roche's momentum in digital pathology continues with FDA clearance on its high-​volume slide scanner PR Newswire
22.12.24 - Boersia.de
Roche Aktie: Ängste vor Verlusten steigen
Die Roche-​Aktie zeigt sich am Ende des Jahres 2024 mit einer schwächeren Performance. Im gestrigen Handel an der SIX Swiss Exchange verzeichnete das Papier des Schweizer ...

Newssuche

Videos

newspaper
10:20 Uhr +0,36%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »